Nycomed GmbH
Records under this name other than patents Nycomed GmbH holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,232,297 | Sulphonylpyrroles as inhibitors of HDACs novel sulphonylpyrroles Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 7,842,820 | Sulfonylpyrroles Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 8,371,292 | Use of Ciclesonide for the Treatment of Respiratory Diseases Formerly held In force · High confidence | In force | High confidence | |
| US 8,481,516 | Ciclesonide containing sterile aqueous suspension Formerly held In force · High confidence | In force | High confidence | |
| US 8,435,497 | Formoterol and Ciclesonide Combination Formerly held In force · High confidence | In force | High confidence | |
| US 8,910,627 | Apparatus for the Aerosolization of Large Volumes of Dry Powder Formerly held In force · High confidence | In force | High confidence | |
| US 9,782,455 | Solid Phase Synthesis of H(GLY2)GLP-2 Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 9,636,470 | Device for Dosing and Dry Nebulization Formerly held In force · High confidence | In force | High confidence | |
| US 9,422,327 | Process for preparing crystalline ciclesonide with defined particle size Formerly held In force · High confidence | In force | High confidence | |
| US 8,003,798 | Novel HYDROXY-6-Heteroarylphenanthridines and Their Use as PDE4 Inhibitors Formerly held Term ended Term ended Jul 9, 2026 · High confidence | Term ended | Term ended Jul 9, 2026 | High confidence |